Pulse Biosciences (PLSE)
(Delayed Data from NSDQ)
$7.69 USD
+0.54 (7.55%)
Updated May 14, 2024 04:00 PM ET
After-Market: $7.70 +0.01 (0.13%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMPrice, Consensus and EPS Surprise
PLSE 7.69 +0.54(7.55%)
Will PLSE be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for PLSE based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for PLSE
Pulse Biosciences, Inc (PLSE) Reports Q2 Loss, Lags Revenue Estimates
Pulse Biosciences, Inc (PLSE) Reports Q1 Loss, Lags Revenue Estimates
PLSE: What are Zacks experts saying now?
Zacks Private Portfolio Services
Pulse Biosciences, Inc (PLSE) Reports Q4 Loss, Lags Revenue Estimates
Other News for PLSE
Pulse Biosciences Enhances Executive Leadership Team
Pulse Biosciences enhances executive leadership team
Pulse Biosciences appoints Burke Barrett as CEO
Pulse Biosciences Inc (PLSE) Q1 2024 Earnings Call Transcript
Pulse Biosciences announces 1st procedure with the CellFX nsPFA electrodes